BCMA-TARGETED CAR-T CELL THERAPY OF MULTIPLE MYELOMA | Patent Publication Number 20210128618

US 20210128618 A1

Patent Number-

Application Number17088845

Filled DateNov 4, 2020

Priority DateNov 5, 2019

Publication DateMay 6, 2021

Original AssigneeJohnson & Johnson

Current AssigneeJanssen Biotech Inc.

Inventor/ApplicantsEnrique ZUDAIRE UBANI

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.